A detailed history of Kennedy Capital Management, Inc. transactions in Essa Pharma Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 41,092 shares of EPIX stock, worth $71,911. This represents 0.01% of its overall portfolio holdings.

Number of Shares
41,092
Previous 34,465 19.23%
Holding current value
$71,911
Previous $181,000 37.57%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.45 - $7.1 $29,490 - $47,051
6,627 Added 19.23%
41,092 $249,000
Q2 2024

Aug 14, 2024

BUY
$4.63 - $8.42 $159,572 - $290,195
34,465 New
34,465 $181,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $77.1M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.